Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy

Currie, Craig John, Poole, Christopher David, Woehl, Anette, Morgan, Christopher L., Cawley, S., Rousculp, M. D., Covington, M. T. and Peters, John Redmond 2007. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabetic Medicine 24 (2) , pp. 187-194. 10.1111/j.1464-5491.2006.02057.x

Full text not available from this repository.

Abstract

Aims: To characterize symptom severity of diabetic peripheral neuropathy (DPN) in people with diabetes and to characterize its association with healthcare resource use. Methods: The study was undertaken in Cardiff and the Vale of Glamorgan, UK. A postal survey was posted to subjects identified as having diabetes. Demography, quality of life (EQ-5D and SF-36) and symptoms of neuropathy (NTSS-6 and QOL-DN) data were collected. These data were linked to routine healthcare data coded into healthcare resource groups (HRGs) and subsequently costed according to UK National reference costs. Results: Survey responses were received from 1298 patients, a 32% response rate. For patients with a clinically confirmed diagnosis of DPN, the mean NTSS-6-SA score was 6.16 vs. 3.19 (P < 0.001). Duration of diabetes did not change across groups defined by severity of neuropathy symptoms, but mean HbA1c and body mass index values did increase with symptom severity (range 7.6–8.1%, P = 0.023; and 28.0–30.9 kg/m2, P < 0.001, respectively). General linear modelling showed that the NTSS-6-SA score was a significant predictor of both annual health resource costs and yearly prescribed drug costs. On average, each 1-point increase in NTSS-6-SA score predicted a 6% increase in primary and secondary care costs and a 3% increase in log transformed drug costs. Conclusion: This study demonstrated that severity of DPN symptoms was associated with increased healthcare resource use, thus costs.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Uncontrolled Keywords: complications; costs; diabetes; peripheral neuropathy; severity
Publisher: Wiley
ISSN: 0742-3071
Last Modified: 31 Jan 2020 10:10
URI: http://orca-mwe.cf.ac.uk/id/eprint/62967

Citation Data

Cited 37 times in Google Scholar. View in Google Scholar

Cited 40 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item